Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Circulating biomarkers for early detection and clinical management of colorectal cancer

M. Marcuello, V. Vymetalkova, RPL. Neves, S. Duran-Sanchon, HM. Vedeld, E. Tham, G. van Dalum, G. Flügen, V. Garcia-Barberan, RJ. Fijneman, A. Castells, P. Vodicka, GE. Lind, NH. Stoecklein, E. Heitzer, M. Gironella,

. 2019 ; 69 (-) : 107-122. [pub] 20190614

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023648

Grantová podpora
NV17-30920A MZ0 CEP - Centrální evidence projektů

New non-invasive approaches that can complement and improve on current strategies for colorectal cancer (CRC) screening and management are urgently needed. A growing number of publications have documented that components of tumors, which are shed into the circulation, can be detected in the form of liquid biopsies and can be used to detect CRC at early stages, to predict response to certain therapies and to detect CRC recurrence in a minimally invasive way. The analysis of circulating tumor DNA (ctDNA), tumor-derived cells (CTC, circulating tumor cells) or circulating microRNA (miRNA) in blood and other body fluids, have a great potential to improve different aspects of CRC management. The challenge now is to find which types of components, biofluids and detection methods would be the most suitable to be applied in the different steps of CRC detection and treatment. This chapter will provide an up to date review on ctDNA, CTCs and circulating miRNAs as new biomarkers for CRC, either for clinical management or early detection, highlighting their advantages and limitations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023648
003      
CZ-PrNML
005      
20201214130719.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.mam.2019.06.002 $2 doi
035    __
$a (PubMed)31189073
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Marcuello, María $u Gastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) / Hospital Clínic of Barcelona/ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
245    10
$a Circulating biomarkers for early detection and clinical management of colorectal cancer / $c M. Marcuello, V. Vymetalkova, RPL. Neves, S. Duran-Sanchon, HM. Vedeld, E. Tham, G. van Dalum, G. Flügen, V. Garcia-Barberan, RJ. Fijneman, A. Castells, P. Vodicka, GE. Lind, NH. Stoecklein, E. Heitzer, M. Gironella,
520    9_
$a New non-invasive approaches that can complement and improve on current strategies for colorectal cancer (CRC) screening and management are urgently needed. A growing number of publications have documented that components of tumors, which are shed into the circulation, can be detected in the form of liquid biopsies and can be used to detect CRC at early stages, to predict response to certain therapies and to detect CRC recurrence in a minimally invasive way. The analysis of circulating tumor DNA (ctDNA), tumor-derived cells (CTC, circulating tumor cells) or circulating microRNA (miRNA) in blood and other body fluids, have a great potential to improve different aspects of CRC management. The challenge now is to find which types of components, biofluids and detection methods would be the most suitable to be applied in the different steps of CRC detection and treatment. This chapter will provide an up to date review on ctDNA, CTCs and circulating miRNAs as new biomarkers for CRC, either for clinical management or early detection, highlighting their advantages and limitations.
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a cirkulující mikroRNA $7 D000074166
650    _2
$a cirkulující nádorová DNA $7 D000074141
650    _2
$a kolorektální nádory $x krev $x diagnóza $x etiologie $x terapie $7 D015179
650    _2
$a management nemoci $7 D019468
650    _2
$a časná detekce nádoru $7 D055088
650    _2
$a lidé $7 D006801
650    _2
$a tekutá biopsie $x metody $7 D000073890
650    _2
$a nádorové cirkulující buňky $7 D009360
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Vymetalkova, Veronika $u Institute of Experimental Medicine of the Czech Academy of Sciences and Institute of Biology and Medical Genetics, First Medical Faculty, Charles University, Prague, Czech Republic.
700    1_
$a Neves, Rui P L $u Experimental Surgical Oncology, General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Duran-Sanchon, Saray $u Gastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) / Hospital Clínic of Barcelona/ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
700    1_
$a Vedeld, Hege Marie $u Department of Molecular Oncology, Institute for Cancer Research, K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway.
700    1_
$a Tham, Emma $u Department of Clinical Genetics, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a van Dalum, Guus $u Experimental Surgical Oncology, General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Flügen, Georg $u Experimental Surgical Oncology, General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Garcia-Barberan, Vanesa $u Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC, Madrid, Spain.
700    1_
$a Fijneman, Remond Ja $u Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
700    1_
$a Castells, Antoni $u Gastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) / Hospital Clínic of Barcelona/ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
700    1_
$a Vodicka, Pavel $u Institute of Experimental Medicine of the Czech Academy of Sciences and Institute of Biology and Medical Genetics, First Medical Faculty, Charles University, Prague, Czech Republic.
700    1_
$a Lind, Guro E $u Department of Molecular Oncology, Institute for Cancer Research, K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway.
700    1_
$a Stoecklein, Nikolas H $u Experimental Surgical Oncology, General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Heitzer, Ellen $u Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz and Christian Doppler Laboratory for Liquid Biopsies for early Detection of Cancer, Austria.
700    1_
$a Gironella, Meritxell $u Gastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) / Hospital Clínic of Barcelona/ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. Electronic address: meritxell.gironella@ciberehd.org.
773    0_
$w MED00003389 $t Molecular aspects of medicine $x 1872-9452 $g Roč. 69, č. - (2019), s. 107-122
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31189073 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130718 $b ABA008
999    __
$a ok $b bmc $g 1595967 $s 1114324
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 69 $c - $d 107-122 $e 20190614 $i 1872-9452 $m Molecular aspects of medicine $n Mol Aspects Med $x MED00003389
GRA    __
$a NV17-30920A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace